NuVascular Technologies Release: Improving Brachytherapy Treatments For Cancer Patients Using Platform Nanotechnology

Ashland, Mass., March 19, 2015 BioSurfaces, Inc., the parent company of NuVascular Technologies, Inc., has partnered with Florida-based cancer-treatment company Microspherix, LLC to improve the effectiveness and reduce the risk of brachytherapy treatment for patients affected by prostate, breast, brain and other cancers. These improvements should make this cost-effective treatment more attractive...